Wearable Injectors Market: Industry Forecast (2023-2029) by Type, Technology Outlook

The Wearable Injectors Market size was valued at US 9.3 Bn. in 2022 and the total Insulation revenue is expected to grow by 15.2% from 2023 to 2029, reaching nearly USD 25.07 Bn. Pharmaceutical development has made significant studies in recent years, and every day, new creative medications are being released into the market. However, the demand to switch medicine delivery from customary settings to more cost-effective options has increased due to the expense and complexity of these novel treatments. Wearable injectors are delivery systems that are attahhed to the body and are used subcutaneously to provide bigger doses of medication (more than 2 mL) over a prolonged period of time. Many pharmaceutical and medical device firms have been leading development efforts to sell Wearable injectors for more than ten years, such as BD LibertasTM large-volume wearable injector Wearable injectors offer a reservoir for the medication, a cannula for distribution to the tissue, adhesive to secure the device to the patient's skin, and a driving system to supply the right amount of drug despite product variations. The difficulty of administering SC injections with increasing dosage volumes and viscosities in non-clinical situations can be successfully overcome with wearable injectors. Patients will be benifited with the convenience of injecting at home thanks to the introduction of strong, modern technologies. Furthermore, being able to adapt novel formulations with higher volume and/or viscosity will allow less frequent injections, to enhance the patient experience, and boost adherence to medicines.

Scope of the Report:

The report provides a comprehensive analysis of the global Wearable Injectors Market. This report estimates the Wearable Injectors Market, in terms of USD value from 2023 to 2029. In order to identify potential investment pockets, this report gives an analytical representation of the Wearable Injectors industry together with current trends and future forecasts. The report includes a thorough analysis of the market share for Wearable Injectors as well as data on important drivers, restraints, and opportunities. A quantitative analysis of the existing market is done from 2023 to 2029 to show the potential for market growth across the globe. In addition, Porter's five forces study demonstrates the market power of both buyers and providers. The research offers a thorough analysis of the worldwide Wearable Injectors market based on the level of competition and how it will develop over the forecast period. MMR research offers crucial information on market size, industry structure, business trends, market share, and predictions that are crucial for creating company plans and strategies. The major strategic and competitive factors influencing the global market are also analysed, along with the major players in the sector and their market shares worldwide.Wearable Injectors MarketTo know about the Research Methodology:-Request Free Sample Report

Wearable Injectors Market Dynamics:

Numerous chronic disease indicators, including diabetes, heart problems, neurological disorders, and oncological disorders, are becoming more common due to the growing world population.This has led to increase , increased demand for effective treatment choices. Additionally, businesses have created unique devices capable of efficiently and relatively simply delivering a number of formulations of various pharmaceuticals and therapies in order to enhance the quality of life for these individuals. Self-injection is a new trend that has been labelled a win-win scenario for patients and medical staff. Self-injection systems are significantly more cost-effective since they provide a lower-cost form of medication administration, which also makes them user-friendly and comfortable for patients. Additionally, by significantly reducing the risk, it reduces the costs related to needlestick injuries. According to reports, these injuries cost the US healthcare system more than USD $1 billion annually. Large capacity wearable injectors have therefore showed a lot of promise to solve this issue. A trend towards self-administration of medications and treatments has emerged in recent years. This is largely due to the availability of several self-injection devices, which have a number of benefits, including increased medication adherence, flexibility with dose, and fewer frequent clinic visits. Furthermore, some with a morbid phobia of needles even prefer these dosing choices. As a result, the demand for Werable Injection devices is increasing, and pharmaceutical companies are currently working to design and develop self-injection technologies for both medicines that are currently on the market and those that are in development. According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-OSHA), there are roughly 3, 85,000 & 1,000,000 needle stick injuries among healthcare workers in the U.S. & Europe, respectively. The World Health Organization reports that NSIs cause 16,000, 66,000, and 1,000 cases of HCV, HBV, and HIV among HCWs each year. As there is no needle sick injuries during the application of Werable injectors the market of Wearable Injectors has shown tremendous growth. The drug delivery industry has been predicting a considerable uptake in the use of Wearable innovative devices, with anticipated compound annual growth rates of over 25% for the next 10 years.Additionally high numbers of new wearable injectors are projected to reach the market in the coming years.The global Wearble Injectors devices market is also driven by a significant rise in demand for home health care, owing to low cost of treatment and improvements in overall patient experience. The market is being driven by the ability of wearable injectors to treat chronic conditions such rheumatoid arthritis, pulmonary arterial hypertension, cardiovascular illness, cancer, Type 1 diabetes, and autoimmune diseases. Additionally, wearable injectors have several cutting-edge characteristics that are increasing their usage among patients globally, which is contributing towards the growth of wearable injectors market. The use of new technologies in mAb-based biotherapy, wearable insulin pumps for at-home drug delivery, and infusion therapy includes the Dual Cartridge Injector, Sonceboz wearable Injector, Auto Reconstitution Injector, Reusable Auto-Injector, Amgen wearable Injector, and Subcutaneous Drug Delivery Devices. The demand for wearable injectors is increasing as a result of the introduction of some cutting-edge injector devices like the QuickDose wearable injector from CCBio, the wearable drug delivery device platform from Sorrel Medical, the on-body injector from E3D, the Ypsodose by Ypsomed, and the SmartDose injector with Freedom60 syringe infusion are contributing towards the growth opportunity of the wearable injector market.

Wearable Injectors Market Segment Analysis:

By Type, Rising demand and the convenience of the skin-contact patches, on-body wearable injectors had the highest revenue share (55.56%) in 2022. Compared to off-body worn injectors, body-wear patch injectors have a far bigger market share. Patients canbwasily administer necessary medicine subcutaneously using body-worn patch injector systems, which are user-friendly.Additionally, the need for body-worn patch injectors is being driven globally by technical improvements and rising acceptance rates.Wearable Injectors Market1By Technology, In 2022, the category of wearable injectors based on springs had the highest share (34.91%). The spring-based sector is expected to dominate the market since it is user-friendly and allows patients to accurately administer the medication subcutaneously by pressing one or more buttons on the device. According to a research, the wearable spring-based Subcuject injector accurately administers a 3 mL, 1 cP viscous dosage in 4 minutes. Given that they are easier to use than other wearable injectors, rotary pump wearable injectors are anticipated to grow at the quickest CAGR of 15.47% throughout the course of the forecast period.Wearable Injectors Market2By End-user, With a market share of around 41.8%, the home care category dominated the wearable injectors market in 2022. The market is expanding as a result of increased demand for home healthcare services, the need for sophisticated medication delivery systems that require little technical knowledge, and a decline in the number of hospital stays for patients. The home care market is also anticipated to be driven by the low cost of wearable injectors and the growing desire to reduce healthcare costs. Additionally, a study found that infusion therapy costs anywhere between USD 200 and USD 1,000 or more, whereas wearable injectors are priced between USD 20 and USD 30. A significant driver of the growth of the home care sector is the price of hospital therapy. The hospital sector is anticipated to grow.

Wearable Injectors Market Regional Insights:

The market in North America, reached USD 2,246.8 million in 2021, and is growing at a CAGR of 16.21% throughout the projected period as a result of the region's advanced healthcare infrastructure, increased prevalence of chronic diseases, and lifestyle-related illnesses. Additionally, the market is anticipated to grow as a result of the local presence of key market participants in the U.S., including Becton, Dickinson and Company, Johnson & Johnson Services, Inc., Unilife Corporation, Steady Med Therapeutics, Inc., Amgen, Inc., and Enable Injections. Rising geriatric population, increased prevalence of chronic diseases, supportive government initiatives, and research into wearable medical devices, Asia Pacific is expanding market for ultra-large volume wearable injectors.

Wearable Injectors Market Scope: Inquire before buying

Wearable Injectors Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 9.3 Bn.
Forecast Period 2023 to 2029 CAGR: 15.2% Market Size in 2029: US $ 25.07 Bn.
Segments Covered: by Type 1. On-body 2. Off-body
by Technology Outlook 1. Spring-based 2. Motor-driven 3. Rotary Pum 4. Expanding Battery 5. Other
by Application Area 1. Oncology 2. Infectious Disease 3. Cardiovascular Disease 4. Autoimmune Disease 5. Other
by End-User 1. Hospital 2. Clinic 3. Home Care 4. Other

Wearable Injectors Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)

Wearable Injectors Market, Key Players are

1. Amgen (US) 2. Becton, Dickinson and Company(US) 3. Steadymed Therapeutics(US) 4. Therapeutics(US) 5. Tandem Diabetes Care, Inc..(US) 6. West Pharmaceutical Services, Inc.(US) 7. Dexcom, Inc.(US) 8. United Therapeutics Corporation(US) 9. Enable Injections(US) 10. Insulet Corporation(US) 11. Medtronic PLC(US) 12. Sensile Medical (A Part of Gerresheimer)(Germany) 13. Sensile Medicals( Israel) 14. E3D Elcam Drug Delivery Devices( Israel) 15. Bespak(UK) 16. Cequr SA(Switzerland) 17. Debiotech S.A(Switzerland) 18. Ypsomed(Switzerland) 19. Zealand Pharma A/S(Denmark) FAQs: 1. What is the study period of the market? Ans. The Global Wearable Injectors Market is studied from 2017-2029. 2. What is the growth rate of Wearable Injectors Market? Ans. The Wearable Injectors Market is growing at a CAGR of 15.2% over forecast period. 3. What is the market size of the Wearable Injectors Market by 2029? Ans. The market size of the Wearable Injectors Market by 2029 is expected to reach at USD 25.07 Bn. 4. What is the forecast period for the Wearable Injectors Market? Ans. The forecast period for the Wearable Injectors Market is 2023-2029. 5. What was the market size of the Wearable Injectors Market in 2022? Ans. The market size of the Wearable Injectors Market in 2022 was valued at USD 9.3 Bn.
1. Global Wearable Injectors Market: Research Methodology 2. Global Wearable Injectors Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Wearable Injectors Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Wearable Injectors Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Wearable Injectors Market Segmentation 4.1 Global Wearable Injectors Market, by Type (2022-2029) • On-body • Off-body 4.2 Global Wearable Injectors Market, by Technology Outlook (2022-2029) • Spring-based • Motor-driven • Rotary Pum • Expanding Battery • Other 4.3 Global Wearable Injectors Market, by Application Area (2022-2029) • Oncology • Infectious Disease • Cardiovascular Disease • Autoimmune Disease • Other 4.4 Global Wearable Injectors Market, by End-User (2022-2029) • Hospital • Clinic • Home Care • Others 5. North America Wearable Injectors Market(2022-2029) 5.1 North America Wearable Injectors Market, by Type (2022-2029) • On-body • Off-body 5.2 North America Wearable Injectors Market, by Technology Outlook (2022-2029) • Spring-based • Motor-driven • Rotary Pum • Expanding Battery • Other 5.3 North America Wearable Injectors Market, by Application Area (2022-2029) • Oncology • Infectious Disease • Cardiovascular Disease • Autoimmune Disease • Other 5.4 Global Wearable Injectors Market, by End-User (2022-2029) • Hospital • Clinic • Home Care • Others 5.4 North America Wearable Injectors Market, by Country (2022-2029) • United States • Canada • Mexico 6. Europe Wearable Injectors Market (2022-2029) 6.1. Europe Wearable Injectors Market, by Type (2022-2029) 6.2. Europe Wearable Injectors Market, by Technology Outlook (2022-2029) 6.3. Europe Wearable Injectors Market, by Application Area (2022-2029) 6.4. Europe Wearable Injectors Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Wearable Injectors Market (2022-2029) 7.1. Asia Pacific Wearable Injectors Market, by Type (2022-2029) 7.2. Asia Pacific Wearable Injectors Market, by Technology Outlook (2022-2029) 7.3. Asia Pacific Wearable Injectors Market, by Application Area (2022-2029) 7.4. Asia Pacific Wearable Injectors Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Wearable Injectors Market (2022-2029) 8.1 Middle East and Africa Wearable Injectors Market, by Type (2022-2029) 8.2. Middle East and Africa Wearable Injectors Market, by Technology Outlook (2022-2029) 8.3. Middle East and Africa Wearable Injectors Market, by Application Area (2022-2029) 8.4. Middle East and Africa Wearable Injectors Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Wearable Injectors Market (2022-2029) 9.1. South America Wearable Injectors Market, by Type (2022-2029) 9.2. South America Wearable Injectors Market, by Technology Outlook (2022-2029) 9.3. South America Wearable Injectors Market, by Application Area (2022-2029) 9.4. South America Wearable Injectors Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Amgen 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Becton, Dickinson and Company 10.3 Enable Injections 10.4 Insulet Corporation 10.5 Medtronic PLC 10.6 Sensile Medical (A Part of Gerresheimer) 10.7 Steadymed Therapeutics 10.8 Tandem Diabetes Care, Inc. 10.9 United Therapeutics Corporation 10.10 Valeritas, Inc. 10.11 Ypsomed 10.12 Therapeutics 10.13 Sensile Medicals 10.14 Bespak 10.15 West Pharmaceutical Services, Inc. 10.16 Dexcom, Inc. 10.17 Cequr SA 10.18 Debiotech S.A 10.19 E3D Elcam Drug Delivery Devices 10.20 Zealand Pharma A/S